The Top Line cover image

Automation, decentralization and the future of CAR-Ts: Advancements in cell & gene therapy manufacturing (Part III)

The Top Line

00:00

Maximizing Efficiency and Cost-Effectiveness in Cell and Gene Therapy Manufacturing

Exploring the crucial collaboration between technology providers and manufacturers in the cell and gene therapy field to streamline production processes and reduce costs, emphasizing early engagement for optimal efficiency and savings.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app